Cargando…

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer

The precise molecular mechanisms responsible for resistance to cisplatin-based chemotherapy in patients with bladder cancer remain elusive, while we have indicated that androgen receptor (AR) activity in urothelial cancer is associated with its sensitivity. Our DNA microarray analysis in control vs....

Descripción completa

Detalles Bibliográficos
Autores principales:	Elahi Najafi, Mohammad Amin, Yasui, Masato, Teramoto, Yuki, Tatenuma, Tomoyuki, Jiang, Guiyang, Miyamoto, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530579/ https://www.ncbi.nlm.nih.gov/pubmed/37762034 http://dx.doi.org/10.3390/ijms241813733

Ejemplares similares

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
por: Jiang, Guiyang, et al.
Publicado: (2021)

Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
por: Teramoto, Yuki, et al.
Publicado: (2021)

FOXO1 inactivation induces cisplatin resistance in bladder cancer
por: Ide, Hiroki, et al.
Publicado: (2020)

Association and Interaction Analyses of GABBR1 and GABBR2 with Nicotine Dependence in European- and African-American Populations
por: Li, Ming D., et al.
Publicado: (2009)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
por: Kashiwagi, Eiji, et al.
Publicado: (2016)

Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy
por: Tatenuma, Tomoyuki, et al.
Publicado: (2023)

Endothelial GABBR2 Regulates Post-ischemic Angiogenesis by Inhibiting the Glycolysis Pathway
por: Zhang, Hongze, et al.
Publicado: (2021)

Androgen Receptor Signaling in Bladder Cancer
por: Li, Peng, et al.
Publicado: (2017)

A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1
por: Longqiu, Yang, et al.
Publicado: (2016)

The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures
por: Ma, Shaochun, et al.
Publicado: (2005)

GABBR1 has a HERV-W LTR in its regulatory region – a possible implication for schizophrenia
por: Hegyi, Hedi
Publicado: (2013)

Newborn genome-wide DNA methylation in association with pregnancy anxiety reveals a potential role for GABBR1
por: Vangeel, Elise Beau, et al.
Publicado: (2017)

miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer
por: Choi, Sujin, et al.
Publicado: (2022)

A case of infantile spasms with three possibly pathogenic de novo missense variants in NF1 and GABBR1
por: Watanabe, Kazuki, et al.
Publicado: (2023)

Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence
por: Yasui, Masato, et al.
Publicado: (2018)

The evolutionary history of effectors downstream of Cdc42 and Rac
por: Cotteret, Sophie, et al.
Publicado: (2002)

Ras Downstream Effector GGCT Alleviates Oncogenic Stress
por: He, Zaoke, et al.
Publicado: (2019)

Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer
por: Sun, Zhangyue, et al.
Publicado: (2023)

ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
por: Inoue, Satoshi, et al.
Publicado: (2018)

Androgens in rheumatoid arthritis: when are they effectors?
por: Cutolo, Maurizio
Publicado: (2009)

Transcriptome analysis to identify the downstream genes of androgen receptor in dermal papilla cells
por: Furuya, Kai, et al.
Publicado: (2022)

Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor
por: IZUMI, KOJI, et al.
Publicado: (2012)

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer
por: Ninomiya, Sahoko, et al.
Publicado: (2019)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection
por: Hu, Ming-Chang, et al.
Publicado: (2013)

Signaling Pathways and Downstream Effectors of Host Innate Immunity in Plants
por: Kumar, Jitendra, et al.
Publicado: (2021)

Androgen deprivation therapy prevents bladder cancer recurrence
por: Izumi, Koji, et al.
Publicado: (2014)

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
por: Yasui, Masato, et al.
Publicado: (2019)

Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence
por: Izumi, Koji, et al.
Publicado: (2016)

NRP2 transcriptionally regulates its downstream effector WDFY1
por: Dutta, Samikshan, et al.
Publicado: (2016)

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021)

ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression
por: Kawahara, Takashi, et al.
Publicado: (2015)

Downstream effectors of light- and phytochrome-dependent regulation of hypocotyl elongation in Arabidopsis thaliana
por: Oh, Sookyung, et al.
Publicado: (2013)

Global view of the RAF-MEK-ERK module and its immediate downstream effectors
por: Santini, Cristina C., et al.
Publicado: (2019)

Rac1 is a downstream effector of PKCα in structural synaptic plasticity
por: Tu, Xun, et al.
Publicado: (2020)

Identification of downstream effectors of retinoic acid specifying the zebrafish pancreas by integrative genomics
por: López-Pérez, Ana R., et al.
Publicado: (2021)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

Direct recognition of pathogen effectors by plant NLR immune receptors and downstream signalling
por: Chen, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jakrigrulj0gmu7vp38vho7dp0